Study: Positive Expiratory Pressure Therapy With And Without Oscillation And Hospital Length Of Stay For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease

Turboforte studies

Study

Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis

Finding

“ Adjunctive therapy with a PEP device versus standard care may reduce hospital LOS in patients admitted for AECOPD.”

Abstract

Introduction: Pharmacologic management of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is well-established. Our aim in the current study is to determine if therapy with a positive expiratory pressure (PEP) device with or without an oscillatory mechanism (OM) in addition to standard care results in a reduction in hospital length of stay (LOS) among patients hospitalized for AECOPD.


Methods: 
Two studies were performed and are reported here. Study 1: Patients admitted with AECOPD and sputum production were enrolled in a prospective trial comparing PEP therapy versus Oscillatory PEP (OPEP) therapy. Study 2: A retrospective historical cohort, matched in a 2 to 1 manner by age, gender, and season of admission, was compared with the prospectively collected data to determine the effect of PEP ± OM versus standard care on hospital LOS.


Results: 
In the prospective trial (Study 1; 91 subjects), median hospital LOS was 3.2 (95% CI 3.0-4.3) days in the OPEP group and 4.8 (95% CI 3.9-6.1) days in the PEP group (p=0.16). In fully adjusted models comparing the prospective trial data with the retrospective cohort (Study 2; 182 subjects), cases had a median hospital LOS of 4.2 days (95% CI 3.8-5.1) versus 5.2 days (95% CI 4.4-6.0) in controls, consistent with a shorter hospital LOS with adjunctive PEP±OM therapy versus standard care (p=0.04).


Conclusion: 
Adjunctive therapy with a PEP device versus standard care may reduce hospital LOS in patients admitted for AECOPD. Although the addition of an OM component to PEP therapy suggests a further reduction in hospital LOS, comprehensive multicenter randomized controlled trials are needed to confirm these findings.

 

https://pubmed.ncbi.nlm.nih.gov/31819393

Cited

Milan S, Bondalapati P, Megally M, et al. Positive Expiratory Pressure Therapy With And Without Oscillation And Hospital Length Of Stay For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2553-2561. Published 2019 Nov 20. doi:10.2147/COPD.S213546

Interested in Turboforte?

Turboforte Lung Physio is a handheld drug-free lung expansion & mucus relief device that helps clear congestion from airways and lungs making breathe easier.

Related News

What are the best Airway Clearance methods?

Each and every day, our body produces mucus to ease the movement of foreign objects inside our airways. But what happens when our body produces too much sticky and viscous mucus?

In diseases that stimulate too much mucus production, like cystic fibrosis, bronchiectasis and COPD, airway clearance techniques and devices are important to clear your airways.

Read More »

What is a flutter valve?

A flutter valve is a one-way valve used in respiratory medicine to prevent air from travelling back along a chest tube.

A flutter valve device, on the other hand, is a device used by individuals to mobilize mucus and expand airways.

When exhaling into the device, a steel ball resting on a cone begins to vibrate, causing oscillation through the whole airway, which in turn mobilizes sticky mucus.

Read More »